Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.

Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.

HIV-1 protease autoprocessing is responsible for liberation of free mature protease (PR) from the Gag-Pol polyprotein precursor. A cell-based model system was previously developed to examine the autoprocessing mechanism of fusion precursors carrying the p6*-PR miniprecursor sandwiched between variou...

Full description

Bibliographic Details
Main Authors:	ChihFeng Tien, Liangqun Huang, Susan M Watanabe, Jordan T Speidel, Carol A Carter, Chaoping Chen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5770051?pdf=render

Similar Items

Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells
by: Chen Chaoping, et al.
Published: (2010-07-01)

Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing
by: Chen Chaoping, et al.
Published: (2010-03-01)

Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions
by: Chen Chaoping, et al.
Published: (2011-10-01)

A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
by: Christopher J Counts, et al.
Published: (2015-01-01)

Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
by: Denmeade, SR, et al.
Published: (2001)

Hedgehog Autoprocessing: From Structural Mechanisms to Drug Discovery
by: Nabin Kandel, et al.
Published: (2022-05-01)

Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
by: Jaeyong Lee, et al.
Published: (2020-11-01)

On and Off: A Dual Role for Cysteine Protease Autoprocessing of C difficile Toxin B on Cytotoxicity vs Proinflammatory Toxin Actions?
by: Xinhua Chen, PhD, et al.
Published: (2018-01-01)

Inositol hexakisphosphate-induced autoprocessing of large bacterial protein toxins.
by: Martina Egerer, et al.
Published: (2010-07-01)

Simplified, enhanced protein purification using an inducible, autoprocessing enzyme tag.
by: Aimee Shen, et al.
Published: (2009-12-01)

Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain
by: Nashaat T. Nashed, et al.
Published: (2022-09-01)

Human Immunodeficiency Virus gag and protease: partners in resistance
by: Fun Axel, et al.
Published: (2012-08-01)

Correction: Toxin B Causes Epithelial Cell Necrosis through an Autoprocessing-Independent Mechanism.
by: Nicole M. Chumbler, et al.
Published: (2012-12-01)

Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.
by: Nicole M Chumbler, et al.
Published: (2012-01-01)

Catalytic activity and autoprocessing of murine caspase-11 mediate noncanonical inflammasome assembly in response to cytosolic LPS
by: Daniel C Akuma, et al.
Published: (2024-01-01)

Dengue Virus Type 2 NS3 Protease and NS2B-NS3 Protease Precursor induce Apoptosis
by: Shafee, N., et al.
Published: (2003)

Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome.
by: Frater, J, et al.
Published: (2002)

Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
by: Kristen C Witt, et al.
Published: (2017-01-01)

Precursors of Viral Proteases as Distinct Drug Targets
by: Taťána Majerová, et al.
Published: (2021-10-01)

Cutaneous Manifestations of Human Immunodeficiency Virus Infection in Taiwan
by: Tien-Yi Tzung
Published: (2004-05-01)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
by: Brunner, T, et al.
Published: (2008)

Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.
by: Moore, M, et al.
Published: (2008)

The role of pharmacogenetics in Efficacy and safety of protease inhibitor based therapy in human immunodeficiency virus type (HIV) infection.
by: A. Yu. Sambyalova, et al.
Published: (2021-12-01)

A Combination of M50I and V151I Polymorphic Mutations in HIV-1 Subtype B Integrase Results in Defects in Autoprocessing
by: Jun Yang, et al.
Published: (2021-11-01)

Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution
by: Piatak Mike, et al.
Published: (2008-06-01)

Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients
by: Dinesh Bure, et al.
Published: (2015-02-01)

EPSTEIN-BARR VIRUS-DRIVEN LYMPHOMAGENESIS IN THE CONTEXT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION
by: Maria Raffaella ePetrara, et al.
Published: (2013-10-01)

Human Immunodeficiency Virus
by: Gupta, R, et al.
Published: (2009)

Human gut microbiome in human immunodeficiency virus and acquired immunodeficiency syndrome‐related diseases: Clinically relevant observations
by: Jordan A. Higgs, et al.
Published: (2022-06-01)

Molecular epidemiology and reverse transcript ase (RT) and protease inhibitors (PR) resistance genotyping of human immunodeficiency virus (HIV) in Kelantan
by: Rafidah Hanim, Shueb
Published: (2012)

Effectiveness of a early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants
by: Maes Philip, et al.
Published: (2008-04-01)

Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease
by: Smeulders Liesbeth, et al.
Published: (2010-10-01)

Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.
by: Maria Letizia Giardino Torchia, et al.
Published: (2010-01-01)

The C-Terminal Domain of RNase H and the C-Terminus Amino Acid Residue Regulate Virus Release and Autoprocessing of a Defective HIV-1 Possessing M50I and V151I Changes in Integrase
by: Tomozumi Imamichi, et al.
Published: (2022-11-01)

Human immunodeficiency virus type 1: Role of proteins in the context of viral life cycle
by: Vikas Jha, et al.
Published: (2022-08-01)

Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus
by: Sevelius JM, et al.
Published: (2012-05-01)

IDENTIFICATION OF ANTIRETROVIRAL MUTATION IN PROTEASE AND REVERSE TRANCRIPTASE INHIBITOR IN HUMAN IMMUNODEFICIENCY VIRUS-1 OF HIV/AIDS PATIENTS IN MIMIKA REGENCY, PAPUA
by: Mirna Widiyanti, et al.
Published: (2017-08-01)

Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal
by: Papanagnou P, et al.
Published: (2015-05-01)

Human Immunodeficiency Virus and Uveitis
by: Mingming Yang, et al.
Published: (2023-02-01)

Human immunodeficiency virus polyarthropathy
by: Priyanka Lakshmanan, et al.
Published: (2016-01-01)